NR3C1 and depressive symptom measurement: Subsequently, the GR agonist dexamethasone (Dex) was administered intrathecally to confirm whether depression-induced nociceptive alternations were mediated by spinal GRs and whether BDNF signaling was modulated by GRs in this situation.